{"id":147890,"date":"2025-04-28T16:58:36","date_gmt":"2025-04-28T11:28:36","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=147890"},"modified":"2025-04-28T16:58:39","modified_gmt":"2025-04-28T11:28:39","slug":"pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/","title":{"rendered":"Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-491788604\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>In today\u2019s trading session, three pharmaceutical companies received regulatory approvals from major health authorities, such as the United States Food and Drug Administration (USFDA) and the European Medicines Agency (EMA), leading to a surge in investor interest.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3603657016\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>These approvals are important because they confirm that the company\u2019s products are safe and effective, allowing them to be sold in more markets. Recently, several Indian pharma companies have caught attention after getting such approvals, which could help them grow their business.<\/p><p><strong>Here&#8217;s a list of pharma stocks currently in focus due to recent regulatory green lights from the US and the EU<\/strong><\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/ZYDUSLIFE\" target=\"_blank\" rel=\"noreferrer noopener\">Zydus Lifesciences Ltd<\/a><\/strong><\/h2><p>Zydus Lifesciences Ltd (formerly Cadila Healthcare) is a leading global pharmaceutical company headquartered in India. It focuses on manufacturing a wide range of generic medicines, including APIs, formulations, and biologics, with a strong presence in the US and European markets.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-1556503259\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>The company received regulatory approval following a surveillance inspection by the USFDA at its API manufacturing facility in Dabhasa, Gujarat. The inspection found some minor issues, but none were serious or related to data tampering. This means the facility meets safety and quality standards, which helps Zydus keep selling and expanding its products globally.<\/p><p>With a market capitalization of Rs. 89,117.11 crores on Monday, the shares of <strong>Zydus Lifesciences Ltd <\/strong>jumped upto 3.3 percent, making a high of Rs. 887.50 per share compared to its previous closing price of Rs. 859.10 per share.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/BIOCON\" target=\"_blank\" rel=\"noreferrer noopener\">Biocon Ltd<\/a><\/strong><\/h2><p>Biocon Ltd is India&#8217;s largest biopharmaceutical company, specializing in biologics, biosimilars, and generic formulations. The company, headquartered in Bangalore, is known for its expertise in biotechnology and offers a wide range of affordable drugs for oncology, diabetes, and autoimmune diseases.&nbsp;<\/p><p>Biocon Biologics, a part of Biocon, got a positive review from a key European health committee for two bone-related medicines (denosumab biosimilars). This is an important step before these drugs can be officially approved and sold across the European Union, helping Biocon grow its presence in global markets.<\/p><p>With a market capitalization of Rs. 38,455.22 crores on Monday, the shares of <strong>Biocon Limited <\/strong>jumped upto 3.3 percent, making a high of Rs. 322.45 per share compared to its previous closing price of Rs. 312.00 per share.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/AUROPHARMA\" target=\"_blank\" rel=\"noreferrer noopener\">Aurobindo Pharma Ltd<\/a><\/strong><\/h2><p>Aurobindo Pharma Ltd is a leading Indian multinational pharmaceutical company that manufactures generic drugs and active pharmaceutical ingredients (APIs). The company specializes in a wide array of therapeutic areas, including antibiotics, antiretrovirals, and oncology.<\/p><div class=\"trade-content-10\" id=\"trade-2440246512\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Aurobindo Pharma\u2019s unit, CuraTeQ Biologics, received a positive opinion from a European health body for its breast cancer treatment drug, Dazublys. This is their third such approval in five months, bringing them closer to their goal of launching 10 biosimilar drugs by 2030, and the Final EU approval is expected by July 2025.<\/p><p>With a market capitalization of Rs. 72,545.03 crores on Monday, the shares of <strong>Aurobindo Pharma Ltd <\/strong>jumped upto 3.4 percent, making a high of Rs. 1259.50 per share compared to its previous closing price of Rs. 1217.85 per share.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Sridhar J<\/strong><\/p><\/blockquote><p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-1371945699\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>In today\u2019s trading session, three pharmaceutical companies received regulatory approvals from major health authorities, such as the United States Food and Drug Administration (USFDA) and the European Medicines Agency (EMA), leading to a surge in investor interest. These approvals are important because they confirm that the company\u2019s products are safe and effective, allowing them to [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":125304,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[948,936,2597],"class_list":["post-147890","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-stock-market","tag-stock-market-news","tag-stocks-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA - Trade Brains Features<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA\" \/>\n<meta property=\"og:description\" content=\"In today\u2019s trading session, three pharmaceutical companies received regulatory approvals from major health authorities, such as the United States Food and Drug Administration (USFDA) and the European Medicines Agency (EMA), leading to a surge in investor interest. These approvals are important because they confirm that the company\u2019s products are safe and effective, allowing them to [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-28T11:28:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-28T11:28:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/\",\"name\":\"Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg\",\"datePublished\":\"2025-04-28T11:28:36+00:00\",\"dateModified\":\"2025-04-28T11:28:39+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA - Trade Brains Features","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA","og_description":"In today\u2019s trading session, three pharmaceutical companies received regulatory approvals from major health authorities, such as the United States Food and Drug Administration (USFDA) and the European Medicines Agency (EMA), leading to a surge in investor interest. These approvals are important because they confirm that the company\u2019s products are safe and effective, allowing them to [&hellip;]","og_url":"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2025-04-28T11:28:36+00:00","article_modified_time":"2025-04-28T11:28:39+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/","url":"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/","name":"Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg","datePublished":"2025-04-28T11:28:36+00:00","dateModified":"2025-04-28T11:28:39+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/USFDA.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stocks-jumps-3-after-securing-regulatory-approvals-from-usfda-and-ema\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/147890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=147890"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/147890\/revisions"}],"predecessor-version":[{"id":147891,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/147890\/revisions\/147891"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/125304"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=147890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=147890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=147890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}